翔宇医疗：股价异常波动，25年前三季度营收增6%净利降40%

Core Viewpoint - The company announced abnormal stock price fluctuations, with a cumulative deviation of 30% in closing prices on specific dates in late 2025, indicating potential volatility in the stock market [1] Financial Performance - For the first three quarters of 2025, the company reported revenue of 537.03 million yuan, representing a year-on-year increase of 6% [1] - The net profit for the same period was 43.98 million yuan, showing a significant year-on-year decline of 40.09% [1] Business Focus - The company is concentrating on non-invasive brain-machine interface technology, although related products had not achieved large-scale sales by the end of 2025, resulting in a small revenue contribution [1]